Daihan Pharmaceutical Co.Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 1.44x

Daihan Pharmaceutical Co.Ltd cash flow reinvestment rate. Daihan Pharmaceutical Co.Ltd (023910) has a Cash Flow Reinvestment Rate of 1.44x as of September 2025, reinvesting ₩13.63 Billion (capex ₩10.79 Billion plus investments ₩-2.84 Billion) from operating cash flow of ₩9.47 Billion. See Daihan Pharmaceutical Co.Ltd (023910) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.44x
(Capex + Investments) / Operating CF

Total Reinvested

₩13.63 Billion
Capex + Investments

Operating Cash Flow

₩9.47 Billion
KRW

Capital Expenditures

₩10.79 Billion
KRW

Cash Flow Reinvestment Rate of Daihan Pharmaceutical Co.Ltd (2014–2024)

Cash flow reinvestment rate of Daihan Pharmaceutical Co.Ltd from 2014 to 2024. Historical reinvestment intensity for Daihan Pharmaceutical Co.Ltd across 11 annual periods. Explore how well can Daihan Pharmaceutical Co.Ltd service its debt to assess how comfortably operating cash covers total debt obligations.

Daihan Pharmaceutical Co.Ltd Cash Flow Reinvestment Rate by Year (2014–2024)

Daihan Pharmaceutical Co.Ltd cash flow reinvestment rate by year from 2014 to 2024. Year-by-year capital reinvestment analysis for Daihan Pharmaceutical Co.Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Daihan Pharmaceutical Co.Ltd.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 2.48x ₩88.43 Billion ₩35.64 Billion ₩15.80 Billion ▲ +145.5%
2023 1.01x ₩39.28 Billion ₩38.86 Billion ₩21.28 Billion ▲ +232.5%
2022 0.30x ₩8.81 Billion ₩29.00 Billion ₩8.62 Billion ▲ +1.7%
2021 0.30x ₩12.13 Billion ₩40.62 Billion ₩11.85 Billion ▼ -8.3%
2020 0.33x ₩10.96 Billion ₩33.63 Billion ₩5.36 Billion ▼ -53.7%
2019 0.70x ₩24.84 Billion ₩35.26 Billion ₩17.30 Billion ▼ -33.8%
2018 1.06x ₩47.80 Billion ₩44.94 Billion ₩46.69 Billion ▲ +2.3%
2017 1.04x ₩21.26 Billion ₩20.45 Billion ₩21.05 Billion ▲ +18.5%
2016 0.88x ₩24.50 Billion ₩27.92 Billion ₩21.90 Billion ▲ +290.5%
2015 0.22x ₩4.04 Billion ₩17.98 Billion ₩3.96 Billion ▼ -82.1%
2014 1.26x ₩11.90 Billion ₩9.48 Billion ₩10.47 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow